LEMAITRE VASCULAR, INC. Restructuring and Related Cost, Number of Positions Eliminated
LEMAITRE VASCULAR, INC. (LMAT) reported Restructuring and Related Cost, Number of Positions Eliminated of 7 Employees for the 1-month period ending 2014-04-30, per its 10-Q filed 2015-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2015-11-06
- LEMAITRE VASCULAR, INC. restructuring and related cost, number of positions eliminated for fiscal 2011 was 6.00 Employee.
Employee
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 12 month |
|---|---|
| 2011-12-31 | 6.00 Employee 10-K · filed 2014-03-21 |
Employees
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 1 month | Restructuring and Related Cost, Number of Positions Eliminated 12 month |
|---|---|---|
| 2014-04-30 | 7.00 Employees 10-Q · filed 2015-11-06 | |
| 2011-12-31 | 6.00 Employees 10-K · filed 2015-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |